Experience of health-system pharmacy administration residents in a longitudinal human resource management program

Lindsey B Poppe Amerine1, Robert P Granko1, Scott W Savage1

  • 1Lindsey B. (Poppe) Amerine, Pharm.D., M.S., BCPS, is Assistant Director of Pharmacy, Department of Pharmacy, University of North Carolina (UNC) Hospitals, Chapel Hill, and Assistant Professor of Clinical Education, Eshelman School of Pharmacy, UNC, Chapel Hill. Robert P. Granko, Pharm.D., M.B.A., is Associate Director of Pharmacy, UNC Hospitals. Scott W. Savage, Pharm.D., M.S., is Associate Director of Pharmacy, UNC Health Care, Chapel Hill, and Assistant Professor of Clinical Education, Eshelman School of Pharmacy, UNC. Rowell Daniels, Pharm.D., M.S., is Director of Pharmacy, UNC Hospitals, and Executive Associate Dean of Clinical Practice, Eshelman School of Pharmacy, UNC. Stephen F. Eckel, Pharm.D., M.H.A., BCPS, FAPhA, FASHP, is Associate Director of Pharmacy, UNC Hospitals, and Clinical Associate Professor, Eshelman School of Pharmacy, UNC.

Abstract

Related Concept Videos

Healthcare Agencies II01:17

Healthcare Agencies II

There are various healthcare agencies in the United States—some of which are managed by religious institutions and others by different government branches.
Parish nursing is a growing specialty nursing profession that focuses on holistic healthcare, health promotion, and illness prevention. It blends professional nursing practice with a health ministry, focusing on health and healing within the context of a Christian community. Parish nurses serve as health educators, referral sources,...
1.1K
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
957
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
375
Documentation in Long-Term and Home Healthcare Setting01:29

Documentation in Long-Term and Home Healthcare Setting

Documentation in long-term care facilities and home healthcare settings is crucial for ensuring continuous, coordinated, and comprehensive care for patients. Each setting has its specific documentation processes and tools:
Long-Term Care Facilities
1.7K
Dosage Regimens: Partial Pharmacokinetic Parameters01:01

Dosage Regimens: Partial Pharmacokinetic Parameters

It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
356
Pharmacokinetic–Pharmacodynamic Relationship: Influence of Elimination Half-Life on Effect Duration01:23

Pharmacokinetic–Pharmacodynamic Relationship: Influence of Elimination Half-Life on Effect Duration

Drug elimination from the body primarily occurs through metabolic and excretion pathways. Hepatic metabolism transforms lipophilic drugs into hydrophilic forms for excretion, typically via enzymatic processes classified as phase I (modification) and phase II (conjugation). Renal excretion eliminates drugs and metabolites through filtration and secretion in the kidneys. Impairment in liver or kidney function can hinder these processes, delaying drug clearance and extending the drug’s...
118